NCT03180736 2025-12-19
EMN14
European Myeloma Network B.V.
Phase 3 Completed
Clinical Trials
6 trialsNCT02990338 2025-01-17
ICARIA-MM
Sanofi
Phase 3 Completed
NCT02726581 2023-03-27
CheckMate 602
Bristol-Myers Squibb
Phase 3 Completed
NCT01712789 2022-01-10
STRATUS
Celgene
Phase 3 Completed
NCT01324947 2019-11-19
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
Celgene
Phase 3 Completed
NCT01243944 2019-03-06
Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)
Incyte Corporation
Phase 3 Completed